Quest Diagnostics Incorporated

0KSX.L | Healthcare | LSE
$176.49
-0.09 (-0.05%)

Key Metrics

Market Cap
$19.72B
P/E Ratio
11.71
EPS
$15.07
Beta
N/A
Dividend Yield
N/A
ROE
13.75%
Current Ratio
1.13

Company Information

Industry
Medical Equipment Services

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated provides diagnostic testing information and services in the United States and internationally The company develops and delivers diagnostic information services such as routine testing nonroutine and advanced clinical testing anatomic pathology testing and other diagnostic information services It offers diagnostic information services primarily under the Quest Diagnostics brand as well as under the AmeriPath Dermpath Diagnostics ExamOne and Quanum brands to patients clinicians hospitals independent delivery networks health plans employers direct contract entities and accountable care organizations through a network of laboratories patient service centers phlebotomists in physician offices call centers and mobile paramedics nurses and other health and wellness professionals The company also provides risk assessment services for the life insurance industry and healthcare organizations and clinicians robust information technology solutions Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus New Jersey

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2025-10-21 $2.60 $2.50 +4.0%
2025-07-22 $2.62 $2.57 +1.9%
2025-04-22 $1.94 $2.15 -9.8%
2025-01-30 $2.23 $2.19 +1.8%

Financial Ratios (TTM)

Gross Margin
33.30%
Operating Margin
14.11%
Net Margin
8.93%
ROA
5.98%
Price to Book
2.72
Price to Sales
1.81